Gene Clouse

Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle.

Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle.

Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle.

Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle.

Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle.

TrialStat Corp. provides clinical data solutions for life science products. It offers customer suport, CROFirst, user training and data center services. The firm serves pharmaceutical, biotechnology and contract research organizations. The company was founded by Peter O'Blenis in 2001 and is headquartered in Ottawa, Canada.